Enrolling by Invitation
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
NCT04976322
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- Sl0046 50140 Birmingham, Alabama, United States
- Sl0046 50058 Avondale, Arizona, United States
- Sl0046 50662 Glendale, Arizona, United States
- Sl0046 50052 Phoenix, Arizona, United States